Form 4: Abbott Labs EVP Sells Shares, Tax Withholding

Abbott Laboratories EVP and Group President Daniel Gesua Sive Salvadori reported the disposition of shares for tax withholding and a subsequent sale.

Summary

• Daniel Gesua Sive Salvadori, EVP and Group President of Abbott Laboratories, reported two transactions involving common shares.
• On February 27, 2026, 6,615 common shares were disposed of at $116.26 per share, likely for tax withholding purposes (Transaction Code F).
• Following this disposition, Salvadori beneficially owned 147,262 common shares.
• On March 2, 2026, an additional 885 common shares were sold at $115.58 per share (Transaction Code S).
• After these transactions, Salvadori's direct beneficial ownership stands at 146,377 common shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. Routine insider sales, especially those related to tax withholding, are common and do not typically signal significant changes in company prospects or executive confidence.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions and typically do not provide broader industry context. These transactions reflect individual executive compensation and tax planning rather than strategic industry shifts.

Stakeholder Impact

• Minimal impact on shareholders as these are routine, relatively small insider transactions. No direct impact on employees, customers, suppliers, or creditors is indicated.

Key Dates

Keywords

Abbott Laboratories, ABT, Insider Trading, Form 4, Stock Sale, Executive Compensation, Daniel Gesua Sive Salvadori, Tax Withholding